NCT05886920
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05886920
Title Study of D3S-002 as Monotherapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors D3 Bio (Wuxi) Co., Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
D3 Bio Investigative Site Detroit Michigan 48202 United States Details
D3 Bio Investigative Site New York New York 10029 United States Details
D3 Bio Investigative Site Blacktown New South Wales 2148 Australia Details
D3 Bio Investigative Site Bedford Park South Australia 5042 Australia Details
D3 Bio Investigative Site Nedlands Western Australia 6009 Australia Details
D3 Bio Investigative Site Beijing Beijing Municipality 100142 China Details
D3 Bio Investigative Site Guangzhou Guangdong 510080 China Details
D3 Bio Investigative Site Harbin Heilong Jiang 150081 China Details
D3 Bio Investigative Site Shanghai Shanghai Municipality 201801 China Details
D3 Bio Investigative Site Hangzhou Zhejiang 310009 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field